Germany
Japan
United Kingdom
China
Antibodies
Download
Caldesmon (CALD1) rabbit monoclonal antibody, clone EP19, Supernatant
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
c-Myc (MYC) mouse monoclonal antibody, clone 9E10, Purified
| Applications | ELISA, FC, IHC, IP, WB |
| Reactivities | Human |
CDK7 mouse monoclonal antibody, clone MO-1.1, Aff - Purified
| Applications | FC, IF, IHC, IP, WB |
c-Myc (MYC) mouse monoclonal antibody, clone 9E10, Purified
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Human |
p53 (TP53) mouse monoclonal antibody, clone B-P3, Azide Free
| Applications | FC, IHC, IP, WB |
| Reactivities | Human |
CNBP mouse monoclonal antibody, clone AT38F10, Purified
| Applications | ELISA, FC, IF, WB |
| Reactivities | Human |
CNBP mouse monoclonal antibody, clone AT38F10, Purified
| Applications | ELISA, FC, IF, WB |
| Reactivities | Human |
Mouse Monoclonal MECT1 / Torc1 Antibody
| Applications | FC, IF, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Mouse Monoclonal SMAD5 (C-terminus) Antibody
| Applications | FC, IF, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
BCL3 hamster monoclonal antibody, clone Ham150-3.5, Purified
| Applications | ELISA, FC, WB |
| Reactivities | Human, Mouse |
c-Myc (MYC) mouse monoclonal antibody, clone 9E10, FITC
| Applications | FC, IF, IHC |
| Reactivities | Human |
| Conjugation | FITC |
Mouse Monoclonal OCT4 Antibody (7E7)
| Applications | FC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
TA336803 is a replacement of AM06533SU-N.
B7-2 (CD86) mouse monoclonal antibody, clone B-T7, Azide Free
| Applications | FC, FN |
| Reactivities | Human |
B7-2 (CD86) mouse monoclonal antibody, clone B-T7, FITC
| Applications | FC |
| Reactivities | Human |
| Conjugation | FITC |
B7-2 (CD86) mouse monoclonal antibody, clone B-T7, Purified
| Applications | FC |
| Reactivities | Human |
Active filters
Applications
- FC
Clonalities
- Monoclonal
Families
- Transcription Factors
Filter by
Target Symbol
- CTNNB1 (82)
- TP53 (81)
- SQSTM1 (54)
- CD80 (51)
- SIRT5 (45)
- STAT5A (45)
- TAL1 (45)
- CD86 (44)
- HDAC6 (40)
- PSMC3 (40)
- SLA2 (40)
- SNAI2 (40)
- STAT4 (40)
- LHX1 (35)
- PPP5C (35)
- SSX1 (35)
- TLE1 (35)
- ELK3 (30)
- FOXI1 (30)
- GAS7 (30)
- HDAC10 (30)
- ID3 (30)
- MEF2C (30)
- GATA3 (25)
- HDAC1 (25)
- PGR (24)
- GTF2F1 (20)
- IRF6 (20)
- PHF7 (20)
- RFXANK (20)
- TNF (18)
- FOXP3 (16)
- ARNT (15)
- KEAP1 (15)
- MAFB (15)
- PBX1 (15)
- PHF21B (15)
- POLR2J2 (15)
- PPARA (15)
- RUVBL2 (15)
- SSB (15)
- ZIM2 (15)
- HES1 (11)
- APEX1 (10)
- ARNTL (10)
- EIF4E2 (10)
- MYC (10)
- MYNN (10)
- RYBP (10)
- SEC14L2 (10)
- SMAD2 (10)
- SOX17 (10)
- TULP3 (10)
- WWTR1 (10)
- TGFB1 (9)
- FOXP1 (6)
- AIP (5)
- ASCC2 (5)
- BACH1 (5)
- BCL3 (5)
- CNOT4 (5)
- CRABP2 (5)
- FOXA2 (5)
- GSC (5)
- HAND1 (5)
- IRF3 (5)
- JUN (5)
- KDM4C (5)
- MEIS1 (5)
- NONO (5)
- POGK (5)
- POLR2E (5)
- SATB1 (5)
- SSX5 (5)
- TLE2 (5)
- TSC22D1 (5)
- ZNF280A (5)
- ZSCAN18 (5)
- CNBP (2)
- LITAF (2)
- NFATC1 (2)
- ATF2 (1)
- ATF6 (1)
- BCL6 (1)
- CALR (1)
- CDK7 (1)
- CREB1 (1)
- DAXX (1)
- EIF4G2 (1)
- HSF1 (1)
- IKBKB (1)
- IKBKG (1)
- NKX3-1 (1)
- PARP1 (1)
- POU5F1 (1)
- PRDM1 (1)
- RELA (1)
- RORC (1)
- SIRT1 (1)
- SMAD5 (1)
Reactivities
Antibody Hosts
Knockout (KO) Validation
Modifications
Pathways
- Pathways in cancer (286)
- Wnt signaling pathway (200)
- Colorectal cancer (197)
- MAPK signaling pathway (193)
- Chronic myeloid leukemia (173)
- Endometrial cancer (173)
- Thyroid cancer (173)
- Prostate cancer (168)
- Basal cell carcinoma (163)
- Cell cycle (136)
- Adherens junction (132)
- Systemic lupus erythematosus (128)
- Huntington's disease (127)
- Toll-like receptor signaling pathway (126)
- Allograft rejection (113)
- Graft-versus-host disease (113)
- Type I diabetes mellitus (113)
- Pancreatic cancer (103)
- Apoptosis (102)
- Amyotrophic lateral sclerosis (ALS) (100)
- Viral myocarditis (96)
- Autoimmune thyroid disease (95)
- Cell adhesion molecules (CAMs) (95)
- Jak-STAT signaling pathway (95)
- Small cell lung cancer (94)
- Bladder cancer (91)
- Neurotrophin signaling pathway (88)
- Focal adhesion (87)
- Melanogenesis (83)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (82)
- Leukocyte transendothelial migration (82)
- Pathogenic Escherichia coli infection (82)
- Tight junction (82)
- Glioma (81)
- Melanoma (81)
- Non-small cell lung cancer (81)
- p53 signaling pathway (81)
- TGF-beta signaling pathway (78)
- ErbB signaling pathway (60)
- Acute myeloid leukemia (58)
- Proteasome (40)
- Adipocytokine signaling pathway (36)
- Notch signaling pathway (36)
- Renal cell carcinoma (29)
- T cell receptor signaling pathway (28)
- Cytokine-cytokine receptor interaction (27)
- Dilated cardiomyopathy (27)
- Hypertrophic cardiomyopathy (HCM) (27)
- RIG-I-like receptor signaling pathway (26)
- Oocyte meiosis (24)
- Progesterone-mediated oocyte maturation (24)
- Antigen processing and presentation (22)
- NOD-like receptor signaling pathway (21)
- Primary immunodeficiency (21)
- Basal transcription factors (20)
- Metabolic pathways (20)
- Natural killer cell mediated cytotoxicity (20)
- Purine metabolism (20)
- Pyrimidine metabolism (20)
- RNA polymerase (20)
- Alzheimer's disease (19)
- Type II diabetes mellitus (19)
- Asthma (18)
- Fc epsilon RI signaling pathway (18)
- Hematopoietic cell lineage (18)
- Maturity onset diabetes of the young (16)
- PPAR signaling pathway (15)
- Ubiquitin mediated proteolysis (15)
- Base excision repair (11)
- Insulin signaling pathway (11)
- B cell receptor signaling pathway (10)
- Circadian rhythm - mammal (10)
- mTOR signaling pathway (10)
- Cytosolic DNA-sensing pathway (8)
- Epithelial cell signaling in Helicobacter pylori infection (8)
- GnRH signaling pathway (5)
- RNA degradation (5)
- Chemokine signaling pathway (3)
- Axon guidance (2)
- VEGF signaling pathway (2)
- Nucleotide excision repair (1)